Mengist Belayneh, Animut Zelalem, Tolossa Tadesse
Department of Public Health, College of Health Sciences, Debre Markos University, Debre Markos, Ethiopia.
Department of Epidemiology and Biostatistics, School of Public Health, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
Int J Afr Nurs Sci. 2022;16:100419. doi: 10.1016/j.ijans.2022.100419. Epub 2022 Apr 30.
Currently, coronavirus disease 2019 (COVID-19) is the leading cause of death and the rate of mortality is rapidly increasing over time. There is a paucity of information regarding the incidence and predictors of mortality among COVID-19 patients from low-income countries, particularly in Ethiopia.
To assess incidence and predictors of mortality among COVID-19 patients admitted to treatment centers in North West Ethiopia.
An institution-based retrospective cohort study was conducted among 552 laboratory-confirmed COVID-19 cases at Debre Markos University and Tibebe Ghion Hospital COVID-19 treatment centers in North West Ethiopia from March 2020 to March 2021. Data were collected from patients' medical records using a structured data extraction tool. Cox-proportional hazards regression models was fitted to identify significant predictors of mortality.
The overall mortality rate of COVID-19 was 4.7, (95 % CI: 3.3-6.8) per 1000 person day observations. Older age (AHR: 4.9; 95% CI: 1.8, 13.5), rural residence (AHR: 0.18; 95% CI: 0.05, 0.64), presence of hypertension (AHR: 3.04; 95% CI: 1.18, 7.8), presence of diabetes mellitus (AHR: 8.1; 95% CI: 2.9, 22.4) and cardiovascular disease (AHR: 5.2; 95% CI: (1.69, 16.2) were significantly associated with mortality.
The rate of mortality among hospitalized COVID-19 patients in this study was low. COVID-19 patients from urban residences, older patients, and patients with comorbidity have a high risk of death. These high risk groups should be prioritized for COVID-19 vaccinations, and early screening and appropriate intervention should be established on presentation to health facility.
目前,2019冠状病毒病(COVID-19)是主要的死亡原因,且死亡率随时间迅速上升。关于低收入国家COVID-19患者的发病率和死亡率预测因素的信息匮乏,尤其是在埃塞俄比亚。
评估埃塞俄比亚西北部治疗中心收治的COVID-19患者的发病率和死亡率预测因素。
2020年3月至2021年3月,在埃塞俄比亚西北部德布雷马科斯大学和提贝贝吉翁医院COVID-19治疗中心,对552例实验室确诊的COVID-19病例进行了一项基于机构的回顾性队列研究。使用结构化数据提取工具从患者病历中收集数据。采用Cox比例风险回归模型确定死亡率的显著预测因素。
COVID-19的总体死亡率为每1000人日观察4.7例(95%可信区间:3.3-6.8)。年龄较大(调整后风险比:4.9;95%可信区间:1.8,13.5)、农村居民(调整后风险比:0.18;95%可信区间:0.05,0.64)、患有高血压(调整后风险比:3.04;95%可信区间:1.18,7.8)、患有糖尿病(调整后风险比:8.1;95%可信区间:2.9,22.4)和心血管疾病(调整后风险比:5.2;95%可信区间:(1.69,16.2)与死亡率显著相关。
本研究中住院COVID-19患者的死亡率较低。来自城市的COVID-19患者、老年患者和合并症患者死亡风险较高。这些高危人群应优先接种COVID-19疫苗,并且在前往医疗机构就诊时应建立早期筛查和适当干预措施。